Resolvin D1 (100 μg/kg, intravenous) did not inhibit an increase in IL-10 post lung I/R injury (Zhao et al., 2016), and MaR1 (4 ng/g body weight) administered prior to ischemia in a rat model of liver I/R injury increased serum IL-10 levels that were otherwise reduced post-I/R injury (Soto et al., 2020). This evidence concerns the gene IL10 and ischemia.